耶鲁医学院人类与转化免疫学（HTI）计划的任务是加快免疫学领域新进展在人类疾病治疗中的应用。HTI计划的管理基地位于免疫生物学系内，其核心实验室位于Amistad大楼和George Street设施中，向所有对人体免疫学和免疫学贡献浓厚兴趣的耶鲁医学院医学院的所有成员开放去疾病。HTI教授研究了非常广泛的人类疾病的免疫学方面，包括癌症和癌症治疗，实体器官和干细胞移植，自身免疫性疾病（包括内分泌疾病，例如1型糖尿病），风湿病（包括类风湿病）等领域的研究。关节炎和系统性红斑狼疮，肺部疾病（包括哮喘和慢性阻塞性
The mission of the Human and Translational Immunology (HTI) Program at the Yale School of Medicine is to accelerate the application of new developments in the field of immunology to the treatment of human diseases. With its administrative base within the Department of Immunobiology and its core laboratories housed in the Amistad building and the George Street Facility, the HTI program is open to all members of the Yale School of Medicine faculty with an interest in human immunology and the contributions of immunology to disease. The HTI faculty study the immunologic aspects of a very broad range of human diseases, encompassing investigations in the fields of cancer and cancer therapeutics, transplantation of solid organs and stem cells, autoimmune diseases including endocrine diseases such as Type 1 diabetes, rheumatologic diseases including rheumatoid arthritis and systemic lupus erythematosis, pulmonary diseases including asthma and chronic obstructive pulmonary disease, neurologic diseases such as multiple sclerosis, gastrointestinal diseases such as Crohn's disease, celiac sprue, and ulcerative colitis, and many others. HTI programs offer investigators the opportunity to interact with other clinical and basic scientists to develop investigations in the treatment of human disease, and access to resources to support this work. Providing resources to develop novel therapies that are in the early stages (Phase I/II) of development are a top priority of HTI, which will assist in preparing applications to the Immune Tolerance Network, the FOCIS Centers of Excellence, Trialnet and other multi-institutional organizations.